2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

Association Between Atrial Fibrillation Symptoms, Quality of Life, and Patient Outcomes: Results From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)

Freeman, J. V., Simon, D. N., Go, A. S., Spertus, J., Fonarow, G. C., Gersh, B. J., Hylek, E. M., Kowey, P. R., Mahaffey, K. W., Thomas, L. E., et al. (2015) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.114.001303 · Cited by 246

Mixed treatment comparison of dronedarone, amiodarone, sotalol, flecainide, and propafenone, for the management of atrial fibrillation

Freemantle, N., Lafuente-Lafuente, C., Mitchell, S., Eckert, L., & Reynolds, M. (2011) · Europace · doi:10.1093/europace/euq450 · Cited by 245

Dynamic Nature of Atrial Fibrillation Substrate During Development and Reversal of Heart Failure in Dogs

Shinagawa, K., Shi, Y., Tardif, J., Leung, T. K., & Nattel, S. (2002) · Circulation · doi:10.1161/01.cir.0000016826.62813.f5 · Cited by 240

Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis

Andreotti, F., Rocca, B., Husted, S., Ajjan, R., ten Berg, J. M., Cattaneo, M., Collet, J., Caterina, R. D., Fox, K. A. A., Halvorsen, S., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv304 · Cited by 239

Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: results of the ADVANCE study

Du, X., Ninomiya, T., de Galan, B., Abadir, E., Chalmers, J., Pillai, A., Woodward, M., Cooper, M., Harrap, S., Hamet, P., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp055 · Cited by 239

Anterior-posterior versus anterior-lateral electrode positions for external cardioversion of atrial fibrillation: a randomised trial

Kirchhof, P. F., Eckardt, L., Loh, P. K. K., Weber, K., Fischer, R., Seidl, K., Böcker, D., BREITHARDT, G. E., Haverkamp, W., & Borggrefe, M. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11315-8 · Cited by 239

Rate vs Rhythm Control in Patients With Atrial Fibrillation: A Meta-analysis

de Denus, S. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.3.258 · Cited by 239

Atrial fibrillation in hypertrophie cardiomyopathy: A longitudinal study

Robinson, K., Frenneaux, M. P., Stockins, B., Karatasakis, G., Poloniecki, J. D., & Mckenna, W. J. (1990) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(10)80014-2 · Cited by 237

Comparison of Transplacental Treatment of Fetal Supraventricular Tachyarrhythmias With Digoxin, Flecainide, and Sotalol: Results of a Nonrandomized Multicenter Study

Jaeggi, E. T., Carvalho, J. S., De Groot, E., Api, O., Clur, S.-A. B., Rammeloo, L., McCrindle, B. W., Ryan, G., Manlhiot, C., & Blom, N. A. (2011) · Circulation · doi:10.1161/circulationaha.111.026120 · Cited by 237

Symptoms and Functional Status of Patients With Atrial Fibrillation: State of the Art and Future Research Opportunities

Rienstra, M., Lubitz, S. A., Mahida, S., Magnani, J. W., Fontes, J. D., Sinner, M. F., Van Gelder, I. C., Ellinor, P. T., & Benjamin, E. J. (2012) · Circulation · doi:10.1161/circulationaha.111.069450 · Cited by 237

Prognosis and treatment of atrial fibrillation patients by European cardiologists: one year follow-up of the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase (EORP-AF Pilot registry)

Lip, G. Y. H., Laroche, C., Ioachim, P. M., Rasmussen, L. H., Vitali-Serdoz, L., Petrescu, L., Darabantiu, D., Crijns, H. J. G. M., Kirchhof, P., Vardas, P., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu374 · Cited by 237

A randomized study of prophylactic catheter ablation in asymptomatic patients with the Wolff-Parkinson-White syndrome

Pappone, C., Santinelli, V., Manguso, F., Augello, G., Santinelli, O., Vicedomini, G., Gulletta, S., Mazzone, P., Tortoriello, V., Pappone, A., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035345 · Cited by 236

Triple therapy with aspirin, prasugrel, and vitamin K antagonists in patients with drug-eluting stent implantation and an indication for oral anticoagulation

Sarafoff, N., Martischnig, A., Wealer, J., Mayer, K., Mehilli, J., Sibbing, D., & Kastrati, A. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.02.036 · Cited by 236

Dronedarone for the control of ventricular rate in permanent atrial fibrillation: The Efficacy and safety of dRonedArone for The cOntrol of ventricular rate during atrial fibrillation (ERATO) study

Davy, J., Herold, M., Höglund, C., Timmermans, A. J. M., ALINGS, A. M. W., Radzik, D., & Kempen, L. V. (2008) · American Heart Journal · doi:10.1016/j.ahj.2008.06.010 · Cited by 235

Safety and Efficacy of Pulmonary Vein Antral Isolation in Patients With Obstructive Sleep Apnea: The Impact of Continuous Positive Airway Pressure

Patel, D., Mohanty, P., Di Biase, L., Shaheen, M., Lewis, W. R., Quan, K., Cummings, J. E., Wang, P., Al-Ahmad, A., Venkatraman, P., et al. (2010) · Circulation: Arrhythmia and Electrophysiology · doi:10.1161/circep.109.858381 · Cited by 234

Stepwise Screening of Atrial Fibrillation in a 75-Year-Old Population: Implications for Stroke Prevention

Engdahl, J., Andersson, L., Mirskaya, M., & Rosenqvist, M. (2013) · Circulation · doi:10.1161/circulationaha.112.126656 · Cited by 233

Age as a Risk Factor for Stroke in Atrial Fibrillation Patients

Marinigh, R., Lip, G. Y. H., Fiotti, N., Giansante, C., & Lane, D. A. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.05.028 · Cited by 232

Comparative effects of antiplatelet, anticoagulant, or combined therapy in patients with valvular and nonvalvular atrial fibrillation

Pérez-Gómez, F., Alegría, E., Berjón, J., Iriarte, J. A., Zumalde, J., Salvador, A., & Mataix, L. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.05.084 · Cited by 232

Reduced incidence of new-onset atrial fibrillation with angiotensin II receptor blockade: the VALUE trial

Schmieder, R. E., Kjeldsen, S. E., Julius, S., McInnes, G. T., Zanchetti, A., & Hua, T. A. (2008) · Journal of Hypertension · doi:10.1097/hjh.0b013e3282f35c67 · Cited by 231

Atrial fibrillation and stroke: new ideas, persisting dilemmas

Halperin, J. L., & Hart, R. G. (1988) · Stroke · doi:10.1161/01.str.19.8.937 · Cited by 231

N-Terminal Pro–B-Type Natriuretic Peptide for Risk Assessment in Patients With Atrial Fibrillation

Hijazi, Z., Wallentin, L., Siegbahn, A., Andersson, U., Christersson, C., Ezekowitz, J., Gersh, B. J., Hanna, M., Hohnloser, S., Horowitz, J., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.11.082 · Cited by 231

Integrated care for chronic conditions: The contribution of the ICCC Framework

Nuño-Solínis, R., Coleman, K., Bengoa, R., & Arce, R. S. (2011) · Health Policy · doi:10.1016/j.healthpol.2011.10.006 · Cited by 230

Fish Oil and Postoperative Atrial Fibrillation

Mozaffarian, D., Marchioli, R., Macchia, A., Silletta, M. G., Ferrazzi, P., Gardner, T. J., Latini, R., Libby, P., Lombardi, F., O’Gara, P. T., et al. (2012) · JAMA · doi:10.1001/jama.2012.28733 · Cited by 230

Improved Detection of Silent Atrial Fibrillation Using 72-Hour Holter ECG in Patients With Ischemic Stroke: A Prospective Multicenter Cohort Study

Grond, M., Jauss, M., Hamann, G., Stark, E., Veltkamp, R., Nabavi, D., Horn, M., Weimar, C., Köhrmann, M., Wachter, R., et al. (2013) · Stroke · doi:10.1161/strokeaha.113.001884 · Cited by 229

Oral beta-blockers for mild to moderate hypertension during pregnancy

Magee, L. A., & Duley, L. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002863 · Cited by 228

Recommendations for participation in leisure-time physical activity and competitive sports of patients with arrhythmias and potentially arrhythmogenic conditions Part II: Ventricular arrhythmias, channelopathies and implantable defibrillators

Heidbüchel, H., Corrado, D., Biffi, A., Hoffmann, E., Panhuyzen-Goedkoop, N. M., Hoogsteen, J., Delise, P., Hoff, P. I., & Pelliccia, A. (2006) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/01.hjr.0000239465.26132.29 · Cited by 228

Untitled work

Goodman (2014) · doi:10.1016/j.jacc.2013.11.013 · Cited by 228

Adenosine-guided pulmonary vein isolation for the treatment of paroxysmal atrial fibrillation: an international, multicentre, randomised superiority trial

Macle, L., Khairy, P., Weerasooriya, R., Novak, P., Verma, A., Willems, S., Arentz, T., Deisenhofer, I., Veenhuyzen, G., Scavée, C., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60026-5 · Cited by 226

Analysis of Cause-Specific Mortality in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Study

Steinberg, J. S., Sadaniantz, A., Kron, J., Krahn, A. D., Denny, D. M., Daubert, J. P., Campbell, W. B., Havranek, E. P., Murray, K. T., Olshansky, B., et al. (2004) · Circulation · doi:10.1161/01.cir.0000118472.77237.fa · Cited by 226

The Cox-Maze Procedure for Lone Atrial Fibrillation

Weimar, T., Schena, S., Bailey, M. S., Maniar, H. S., Schuessler, R. B., Cox, J. L., & Damiano, R. J. (2011) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.111.963819 · Cited by 226

Association of metformin with lower atrial fibrillation risk among patients with type 2 diabetes mellitus: a population-based dynamic cohort and in vitro studies

Chang, S.-H., Wu, L.-S., Chiou, M.-J., Liu, J.-R., Yu, K.-H., Kuo, C.-F., Wen, M.-S., Chen, W.-J., Yeh, Y.-H., & See, L.-C. (2014) · Cardiovascular Diabetology · doi:10.1186/s12933-014-0123-x · Cited by 225

Excellent survival and low incidence of arrhythmias, stroke and heart failure long-term after surgical ASD closure at young age. A prospective follow-up study of 21-33 years

Roos-Hesselink, J. (2003) · European Heart Journal · doi:10.1016/s0195-668x(02)00383-4 · Cited by 224

Bleeding with anticoagulation therapy – Who is at risk, and how best to identify such patients

Cosmi, B., & Palareti, G. (2009) · Thrombosis and Haemostasis · doi:10.1160/th08-11-0730 · Cited by 224

Cardiac arrhythmias in pregnancy: clinical and therapeutic considerations

Gowda, R. M., Khan, I. A., Mehta, N. J., Vasavada, B. C., & Sacchi, T. J. (2003) · International Journal of Cardiology · doi:10.1016/s0167-5273(02)00601-0 · Cited by 220

Body Mass Index, Obstructive Sleep Apnea, and Outcomes of Catheter Ablation of Atrial Fibrillation

JONGNARANGSIN, K., CHUGH, A., GOOD, E., MUKERJI, S., DEY, S., CRAWFORD, T., SARRAZIN, J. F., KUHNE, M., CHALFOUN, N., WELLS, D., et al. (2008) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2008.01118.x · Cited by 219

Chromosome 4q25 Variants and Atrial Fibrillation Recurrence After Catheter Ablation

Husser, D., Adams, V., Piorkowski, C., Hindricks, G., & Bollmann, A. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.11.041 · Cited by 218

Continuous stroke unit electrocardiographic monitoring versus 24-hour Holter electrocardiography for detection of paroxysmal atrial fibrillation after stroke

Rizos, T., Güntner, J., Jenetzky, E., Marquardt, L., Reichardt, C., Becker, R., Reinhardt, R., Hepp, T., Kirchhof, P., Aleynichenko, E., et al. (2012) · Stroke · doi:10.1161/strokeaha.112.654954 · Cited by 218

Risk factors for anticoagulation-related bleeding complications in patients with atrial fibrillation: a systematic review

Hughes, M., Lip, G. Y. H., & on behalf of the Guideline Development Group for the NICE national clinical guideline for management of atrial fibrillation in primary and secondary care (2007) · QJM · doi:10.1093/qjmed/hcm076 · Cited by 217

Lone Atrial Fibrillation

Wyse, D. G., Gelder, I. C. V., Ellinor, P. T., Go, A. S., Kalman, J. M., Narayan, S. M., Nattel, S., Schotten, U., & Rienstra, M. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.01.023 · Cited by 217

Warfarin reversal

Hanley, J. P. (2004) · Journal of Clinical Pathology · doi:10.1136/jcp.2003.008904 · Cited by 215

Intravenous Dofetilide, a Class III Antiarrhythmic Agent, for the Termination of Sustained Atrial Fibrillation or Flutter

Falk, R. H., Pollak, A., Singh, S. N., & Friedrich, T. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(96)00506-2 · Cited by 215

Intravenous Amiodarone for Acute Heart Rate Control in the Critically Ill Patient With Atrial Tachyarrhythmias

Clemo, H. F., Wood, M. A., Gilligan, D. M., & Ellenbogen, K. A. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)00962-4 · Cited by 214

Amiodarone Pulmonary Toxicity

Wolkove, N., & Baltzan, M. (2009) · Canadian Respiratory Journal · doi:10.1155/2009/282540 · Cited by 214

The Atrial Fibrillation Ablation Pilot Study: an European Survey on Methodology and results of catheter ablation for atrial fibrillation conducted by the European Heart Rhythm Association

Arbelo, E., Brugada, J., Hindricks, G., Maggioni, A. P., Tavazzi, L., Vardas, P., Laroche, C., Anselme, F., Inama, G., Jais, P., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu001 · Cited by 212

Early Safety and Efficacy of Percutaneous Left Atrial Appendage Suture Ligation

Price, M. J., Gibson, D. N., Yakubov, S. J., Schultz, J. C., Biase, L. D., Natale, A., Burkhardt, J. D., Pershad, A., Byrne, T., Gidney, B., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.03.057 · Cited by 212

Matrix metalloproteinases and atrial remodeling in patients with mitral valve disease and atrial fibrillation

ANNE, W., WILLEMS, R., ROSKAMS, T., SERGEANT, P., HERIJGERS, P., HOLEMANS, P., ECTOR, H., & HEIDBUCHEL, H. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.04.016 · Cited by 210

A clinical prediction rule to identify patients with atrial fibrillation and a low risk for stroke while taking aspirin

van Walraven, C., Hart, R. G., Wells, G. A., Petersen, P., Koudstaal, P. J., Gullov, A. L., Hellemons, B. S. P., Koefed, B. G., & Laupacis, A. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.8.936 · Cited by 209

Educational intervention improves anticoagulation control in atrial fibrillation patients: the TREAT randomised trial

Clarkesmith, D. E., Pattison, H. M., Lip, G. Y. H., & Lane, D. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074037 · Cited by 209

Increased Mortality Associated With Digoxin in Contemporary Patients With Atrial Fibrillation

Turakhia, M. P., Santangeli, P., Winkelmayer, W. C., Xu, X., Ullal, A. J., Than, C. T., Schmitt, S., Holmes, T. H., Frayne, S. M., Phibbs, C. S., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.03.060 · Cited by 208

Benefit of anticoagulation unlikely in patients with atrial fibrillation and a CHA2DS2-VASc score of 1

Friberg, L., Skeppholm, M., & Terént, A. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.10.052 · Cited by 207

Integrating genetic, transcriptional, and functional analyses to identify 5 novel genes for atrial fibrillation

Sinner, M. F., Tucker, N. R., Lunetta, K. L., Ozaki, K., Smith, J. G., Trompet, S., Bis, J. C., Lin, H., Chung, M. K., Nielsen, J. B., et al. (2014) · Circulation · doi:10.1161/circulationaha.114.009892 · Cited by 205

Meta-analysis of gender differences in residual stroke risk and major bleeding in patients with nonvalvular atrial fibrillation treated with oral anticoagulants

Pancholy, S. B., Sharma, P. S., Pancholy, D. S., Patel, T. M., Callans, D. J., & Marchlinski, F. E. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.10.035 · Cited by 204

Warfarin in atrial fibrillation patients with moderate chronic kidney disease

Hart, R. G., Pearce, L. A., Asinger, R. W., & Herzog, C. A. (2011) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02400311 · Cited by 204

Surgery for permanent atrial fibrillation: impact of patient factors and lesion set

Gillinov, A. M., Bhavani, S., Blackstone, E. H., Rajeswaran, J., Svensson, L. G., Navia, J. L., Pettersson, B. G., Sabik, J. F., Smedira, N. G., Mihaljevic, T., et al. (2006) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2006.02.030 · Cited by 203

Early and comprehensive management of atrial fibrillation: executive summary of the proceedings from the 2nd AFNET-EHRA consensus conference ‘research perspectives in AF’

Kirchhof, P., Bax, J., Blomstrom-Lundquist, C., Calkins, H., Camm, A. J., Cappato, R., Cosio, F., Crijns, H., Diener, H.-C., Goette, A., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp235 · Cited by 202

Effect of Cardiac Resynchronization on the Incidence of Atrial Fibrillation in Patients With Severe Heart Failure

Hoppe, U. C., Casares, J. M., Eiskjær, H., Hagemann, A., Cleland, J. G. F., Freemantle, N., & Erdmann, E. (2006) · Circulation · doi:10.1161/circulationaha.106.614560 · Cited by 202

Efficacy and Safety of Prescription Omega-3 Fatty Acids for the Prevention of Recurrent Symptomatic Atrial Fibrillation: A Randomized Controlled Trial

Kowey, P. R., Reiffel, J. A., Ellenbogen, K. A., Naccarelli, G. V., & Pratt, C. M. (2010) · JAMA · doi:10.1001/jama.2010.1735 · Cited by 201

Obesity is a major determinant of radiation dose in patients undergoing pulmonary vein isolation for atrial fibrillation

Ector, J., Dragusin, O., Adriaenssens, B., Huybrechts, W., Willems, R., Ector, H., & Heidbüchel, H. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.03.040 · Cited by 201

Bleeding risk in ‘real world’ patients with atrial fibrillation: comparison of two established bleeding prediction schemes in a nationwide cohort

Olesen, J. B., Lip, G. Y. H., Hansen, P. R., Lindhardsen, J., Ahlehoff, O., Andersson, C., Weeke, P. E., Hansen, M. L., Gislason, G., & Torp-Pedersen, C. T. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04378.x · Cited by 201

Atrial fibrillation and heart failure due to reduced versus preserved ejection fraction: A systematic review and meta-analysis of death and adverse outcomes

Kotecha, D., Chudasama, R., Lane, D. A., Kirchhof, P., & Lip, G. Y. H. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.10.220 · Cited by 199

Effects of amiodarone administration during pregnancy on neonatal thyroid function and subsequent neurodevelopment

Bartalena, L., Bogazzi, F., Braverman, L. E., & Martino, E. (2001) · Journal of Endocrinological Investigation · doi:10.1007/bf03343825 · Cited by 199

Effect of atrial fibrillation on atrial thrombogenesis in humans: impact of rate and rhythm

Lim, H. S., Willoughby, S. R., Schultz, C., Gan, C., Alasady, M., Lau, D. H., Leong, D. P., Brooks, A. G., Young, G. D., Kistler, P. M., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.11.046 · Cited by 199

Guidelines on the prevention and management of de novo atrial fibrillation after cardiac and thoracic surgery

Dunning, J., Treasure, T., Versteegh, M. I. M., & Nashef, S. A. M. (2006) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/j.ejcts.2006.09.003 · Cited by 198

Hypertension and atrial fibrillation: diagnostic approach, prevention and treatment. Position paper of the Working Group ‘Hypertension Arrhythmias and Thrombosis’ of the European Society of Hypertension

Manolis, A. J., Rosei, E. A., Coca, A., Cifkova, R., Erdine, S. E., Kjeldsen, S., Lip, G. Y. H., Narkiewicz, K., Parati, G., Redon, J., et al. (2012) · Journal of Hypertension · doi:10.1097/hjh.0b013e32834f03bf · Cited by 198

New oral anticoagulants in addition to single or dual antiplatelet therapy after an acute coronary syndrome: a systematic review and meta-analysis

Oldgren, J., Wallentin, L., Alexander, J. H., James, S., Jonelid, B., Steg, G., & Sundstrom, J. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht049 · Cited by 198

Clinical characteristics and outcomes with rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation but underlying native mitral and aortic valve disease participating in the ROCKET AF trial

Breithardt, G., Baumgartner, H., Berkowitz, S. D., Hellkamp, A. S., Piccini, J. P., Stevens, S. R., Lokhnygina, Y., Patel, M. R., Halperin, J. L., Singer, D. E., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu305 · Cited by 196

Treatment of arrhythmias during pregnancy

Page, R. L. (1995) · American Heart Journal · doi:10.1016/0002-8703(95)90090-x · Cited by 195

Severe Renal Impairment and Stroke Prevention in Atrial Fibrillation

Marinigh, R., Lane, D. A., & Lip, G. Y. H. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.12.013 · Cited by 195

Efficacy of catheter ablation of atrial fibrillation in patients with obstructive sleep apnoea with and without continuous positive airway pressure treatment: a meta-analysis of observational studies

Li, L., Wang, Z., Li, J., Ge, X., Guo, L., Wang, Y., Guo, W., Jiang, C. X., & Ma, C.-S. (2014) · EP Europace · doi:10.1093/europace/euu066 · Cited by 194

Thoracoscopic Video-Assisted Pulmonary Vein Antrum Isolation, Ganglionated Plexus Ablation, and Periprocedural Confirmation of Ablation Lesions: First Results of a Hybrid Surgical-Electrophysiological Approach for Atrial Fibrillation

Krul, S. P. J., Driessen, A. H. G., van Boven, W. J., Linnenbank, A. C., Geuzebroek, G. S. C., Jackman, W. M., Wilde, A. A. M., de Bakker, J. M. T., & de Groot, J. R. (2011) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.111.961862 · Cited by 194

Vernakalant Hydrochloride for the Rapid Conversion of Atrial Fibrillation After Cardiac Surgery

Kowey, P. R., Dorian, P., Mitchell, L. B., Pratt, C. M., Roy, D., Schwartz, P. J., Sadowski, J., Sobczyk, D., Bochenek, A. A., & Toft, E. S. (2009) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.109.870204 · Cited by 193

Atrial remodeling, autonomic tone, and lifetime training hours in nonelite athletes

Wilhelm, M., Roten, L., Tanner, H., Wilhelm, I., Schmid, J.-P., & Saner, H. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.03.086 · Cited by 192

Lack of evidence of increased mortality among patients with atrial fibrillation taking digoxin: findings from post hoc propensity-matched analysis of the AFFIRM trial

Gheorghiade, M., Fonarow, G. C., van Veldhuisen, D. J., Cleland, J. G. F., Butler, J., Epstein, A. E., Patel, K., Aban, I. B., Aronow, W. S., Anker, S. D., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht120 · Cited by 192

Risk of Falls and Major Bleeds in Patients on Oral Anticoagulation Therapy

Donzé, J. D., Clair, C., Hug, B. L., Rodondi, N., Waeber, G., Cornuz, J., & Aujesky, D. (2012) · The American Journal of Medicine · doi:10.1016/j.amjmed.2012.01.033 · Cited by 192

Left Atrial Radiofrequency Ablation During Mitral Valve Surgery for Continuous Atrial Fibrillation

Doukas, G., Samani, N. J., Alexiou, C., Öç, M., Chin, D. T., Stafford, P. G., Ng, L. L., & Spyt, T. J. (2005) · JAMA · doi:10.1001/jama.294.18.2323 · Cited by 191

Radiofrequency ablation vs. antiarrhythmic drug therapy as first line treatment of symptomatic atrial fibrillation: systematic review and meta-analysis

Hakalahti, A., Biancari, F., Nielsen, J. C., & Raatikainen, M. J. P. (2015) · Europace · doi:10.1093/europace/euu376 · Cited by 191

The HAS-BLED Score Has Better Prediction Accuracy for Major Bleeding Than CHADS2 or CHA2DS2-VASc Scores in Anticoagulated Patients With Atrial Fibrillation

Roldán, V., Marín, F. R., Manzano‐Fernández, S., Gallego, P., Vilchez, J. A., Valdés, M., Vicente, V., & Lip, G. Y. H. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.08.1623 · Cited by 190

Gender-related differences in catheter ablation of atrial fibrillation

Forleo, G. B., Tondo, C., De Luca, L., Russo, A. D., Casella, M., De Sanctis, V., Clementi, F., Fagundes, R. L., Leo, R., Romeo, F., et al. (2007) · EP Europace · doi:10.1093/europace/eum144 · Cited by 189

Clinical Classifications of Atrial Fibrillation Poorly Reflect Its Temporal Persistence

Charitos, E. I., Pürerfellner, H., Glotzer, T. V., & Ziegler, P. D. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.04.019 · Cited by 188

Effectiveness of the Maze Procedure Using Cooled-Tip Radiofrequency Ablation in Patients With Permanent Atrial Fibrillation and Rheumatic Mitral Valve Disease

Filho, C. A. C. A., Lisboa, L. A. F., Dallan, L. A. O., Spina, G. S., Grinberg, M., Scanavacca, M., Sosa, E., Ramires, J. A. F., & de Oliveira, S. A. (2005) · Circulation · doi:10.1161/circulationaha.104.526301 · Cited by 188

A Gain-of-Function TBX5 Mutation Is Associated With Atypical Holt–Oram Syndrome and Paroxysmal Atrial Fibrillation

Postma, A. V., van de Meerakker, J. B. A., Mathijssen, I. B., Barnett, P., Christoffels, V. M., Ilgun, A., Lam, J., Wilde, A. A. M., Deprez, R. H. L., & Moorman, A. F. M. (2008) · Circulation Research · doi:10.1161/circresaha.107.168294 · Cited by 187

Angiotensin II-antagonist in paroxysmal atrial fibrillation (ANTIPAF) trial

Goette, A., Schön, N., Kirchhof, P., Breithardt, G., Fetsch, T., Häusler, K. G., Klein, H. U., Steinbeck, G., Wegscheider, K., & Meinertz, T. (2012) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.111.965178 · Cited by 187

Warfarin Discontinuation After Starting Warfarin for Atrial Fibrillation

Fang, M. C., Go, A. S., Chang, Y., Borowsky, L. H., Pomernacki, N. K., Udaltsova, N. V., & Singer, D. E. (2010) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.110.937680 · Cited by 185

Association between incomplete surgical ligation of left atrial appendage and stroke and systemic embolization

Aryana, A., Singh, S. K., Singh, S. M., Gearoid O’Neill, P., Bowers, M. R., Allen, S. L., Lewandowski, S. L., Vierra, E. C., & d’Avila, A. (2015) · Heart Rhythm · doi:10.1016/j.hrthm.2015.03.028 · Cited by 184

Amiodarone versus placebo and class Ic drugs for cardioversion of recent-onset atrial fibrillation: a meta-analysis

Chevalier, P., Durand-Dubief, A., Burri, H., Cucherat, M., Kirkorian, G., & Touboul, P. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02705-5 · Cited by 184

Impact of rate versus rhythm control on quality of life in patients with persistent atrial fibrillationResults from a prospective randomized study

GRONEFELD, G. (2003) · European Heart Journal · doi:10.1016/s0195-668x(03)00261-6 · Cited by 184

Maintenance of sinus rhythm with an ablation strategy in patients with atrial fibrillation is associated with a lower risk of stroke and death

Hunter, R. J., McCready, J., Diab, I., Page, S. P., Finlay, M., Richmond, L., French, A., Earley, M. J., Sporton, S., Jones, M., et al. (2012) · Heart · doi:10.1136/heartjnl-2011-300720 · Cited by 183

Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: An exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials

Flaker, G. C., Gruber, M. J., Connolly, S. J., Goldman, S. M., Chaparro, S. V., Vahanian, A. S., Halinen, M., Horrow, J. C., & Halperin, J. L. (2006) · American Heart Journal · doi:10.1016/j.ahj.2006.06.024 · Cited by 181

Prevalence of atrial fibrillation in the general population and in high-risk groups: the ECHOES study

Davis, R. C., Hobbs, F. D. R., Kenkre, J. E., Roalfe, A. K., Iles, R., Lip, G. Y. H., & Davies, M. K. (2012) · Europace · doi:10.1093/europace/eus087 · Cited by 180

Safety and Efficacy of Enoxaparin Compared With Unfractionated Heparin and Oral Anticoagulants for Prevention of Thromboembolic Complications in Cardioversion of Nonvalvular Atrial Fibrillation

Stellbrink, C., Nixdorff, U., Hofmann, T., Lehmacher, W., Daniel, W. G., Hanrath, P., Geller, J. C., Mügge, A., Sehnert, W., Schmidt‐Lucke, C., et al. (2004) · Circulation · doi:10.1161/01.cir.0000120509.64740.dc · Cited by 180

Prevalence of early-onset atrial fibrillation in congenital long QT syndrome

Johnson, J. N., Tester, D. J., Perry, J., Salisbury, B. A., Reed, C. R., & Ackerman, M. J. (2008) · Heart Rhythm · doi:10.1016/j.hrthm.2008.02.007 · Cited by 179

“Meta-Analysis of Ablation of Atrial Flutter and Supraventricular Tachycardia”

Navarese, E. P., Lupi, A., Buffon, A., & Luca, G. D. (2010) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.10.011 · Cited by 179

Rate- and Rhythm-Control Therapies in Patients With Atrial Fibrillation: A Systematic Review

Al-Khatib, S. M., Allen LaPointe, N. M., Chatterjee, R., Crowley, M. J., Dupre, M. E., Kong, D. F., Lopes, R. D., Povsic, T. J., Raju, S. S., Shah, B., et al. (2014) · Annals of Internal Medicine · doi:10.7326/m13-1467 · Cited by 178

An Update on the Prognosis of Patients With Atrial Fibrillation

McManus, D. D., Rienstra, M., & Benjamin, E. J. (2012) · Circulation · doi:10.1161/circulationaha.112.129759 · Cited by 178

Treatment of Obstructive Hypertrophic Cardiomyopathy Symptoms and Gradient Resistant to First-Line Therapy With β-Blockade or Verapamil

Sherrid, M. V., Shetty, A., Winson, G., Kim, B., Musat, D., Alviar, C. L., Homel, P., Balaram, S. K., & Swistel, D. G. (2013) · Circulation Heart Failure · doi:10.1161/circheartfailure.112.000122 · Cited by 178

Acute treatment of recent-onset atrial fibrillation and flutter with a tailored dosing regimen of intravenous amiodarone

Hou, Z., Chang, M.-S., CHEN, C., TU, M.-S., Lin, S., CHIANG, H.-T., & Woosley, R. L. (1995) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a060945 · Cited by 178

Arrhythmias after the Fontan procedure

Peters, N. S., & Somerville, J. (1992) · Heart · doi:10.1136/hrt.68.8.199 · Cited by 178

Apixaban versus aspirin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a predefined subgroup analysis from AVERROES, a randomised trial

Diener, H.-C., Eikelboom, J., Connolly, S. J., Joyner, C. D., Hart, R. G., Lip, G. Y., O'Donnell, M., Hohnloser, S. H., Hankey, G. J., Shestakovska, O., et al. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70017-0 · Cited by 177

Comparison of intravenous flecainide, propafenone, and amiodarone for conversion of acute atrial fibrillation to sinus rhythm

Martínez‐Marcos, F. J., Garmendia, J. L. G., Ortega-Carpio, A., Fernández-Gómez, J. M., Santos, J. M., & Camacho, C. (2000) · The American Journal of Cardiology · doi:10.1016/s0002-9149(00)01128-0 · Cited by 177

Feasibility and Safety of Uninterrupted Rivaroxaban for Periprocedural Anticoagulation in Patients Undergoing Radiofrequency Ablation for Atrial Fibrillation

Lakkireddy, D., Reddy, Y. M., Di Biase, L., Vallakati, A., Mansour, M. C., Santangeli, P., Gangireddy, S., Swarup, V., Chalhoub, F., Atkins, D., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.11.039 · Cited by 177

Short-term versus long-term antiarrhythmic drug treatment after cardioversion of atrial fibrillation (Flec-SL): a prospective, randomised, open-label, blinded endpoint assessment trial

Kirchhof, P., Andresen, D., Bosch, R., Borggrefe, M., Meinertz, T., Parade, U., Ravens, U., Samol, A., Steinbeck, G., Treszl, A., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60570-4 · Cited by 176

Is female sex a risk factor for stroke and thromboembolism in patients with atrial fibrillation? A systematic review and meta-analysis

Wagstaff, A. J., Overvad, T. F., Lip, G. Y. H., & Lane, D. A. (2014) · QJM · doi:10.1093/qjmed/hcu054 · Cited by 176

A randomized study of prophylactic catheter ablation in asymptomatic patients with the wolff-parkinson-white syndrome

Pappone, C., Santinelli, V., & Manguso, F. (2004) · ACC Current Journal Review · doi:10.1016/j.accreview.2003.12.058 · Cited by 175

Five-year follow-up after catheter ablation of persistent atrial fibrillation using the stepwise approach and prognostic factors for success

Schreiber, D., Rostock, T., Fröhlich, M., Sultan, A., Servatius, H., Hoffmann, B. A., Lüker, J., Berner, I., Schäffer, B., Wegscheider, K., et al. (2015) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.114.001672 · Cited by 175

Amiodarone versus diltiazem for rate control in critically ill patients with atrial tachyarrhythmias

Karth, G. D., Geppert, A., Neunteufl, T., Priglinger, U., Haumer, M., Gschwandtner, M. E., Siostrzonek, P., & Heinz, G. (2001) · Critical Care Medicine · doi:10.1097/00003246-200106000-00011 · Cited by 174

Catheter Ablation of Atrial Fibrillation in Patients With Left Ventricular Systolic Dysfunction: A Systematic Review and Meta-Analysis

Anselmino, M., Matta, M., D’Ascenzo, F., Bunch, T. J., Schilling, R. J., Hunter, R. J., Pappone, C., Neumann, T., Noelker, G., Fiala, M., et al. (2014) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.114.001938 · Cited by 174

Impact of intensive glycemic control on the incidence of atrial fibrillation and associated cardiovascular outcomes in patients with type 2 diabetes mellitus (from the Action to Control Cardiovascular Risk in Diabetes Study)

Fatemi, O., Yuriditsky, E., Tsioufis, C., Tsachris, D., Morgan, T., Basile, J., Bigger, T., Cushman, W., Goff, D., Soliman, E. Z., et al. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2014.07.045 · Cited by 173

Adjusted-dose warfarin versus aspirin for preventing stroke in patients with atrial fibrillation

Hart, R. G., Pearce, L. A., & Aguilar, M. I. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-8-200710160-00018 · Cited by 173

Omega-3 Fatty Acid Supplementation Does Not Reduce Risk of Atrial Fibrillation After Coronary Artery Bypass Surgery

Saravanan, P., Bridgewater, B., West, A. L., O'Neill, S. C., Calder, P. C., & Davidson, N. C. (2009) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.109.899633 · Cited by 172

Physician practices regarding contraindications to oral anticoagulation in atrial fibrillation: Findings from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry

O'Brien, E. C., Holmes, D. N., Ansell, J., Allen, L. A., Hylek, E. M., Kowey, P. R., Gersh, B. J., Fonarow, G. C., Koller, C. R., Ezekowitz, M. D., et al. (2014) · American Heart Journal · doi:10.1016/j.ahj.2013.12.014 · Cited by 171

Left atrial remodelling in mitral regurgitation—methodologic approach, physiological determinants, and outcome implications: a prospective quantitative Doppler-echocardiographic and electron beam-computed tomographic study

Messika-Zeitoun, D., Bellamy, M., Avierinos, J.-F., Breen, J., Eusemann, C., Rossi, A., Behrenbeck, T., Scott, C., Tajik, J. A., & Enriquez-Sarano, M. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm199 · Cited by 171

Improved suppression of recurrent atrial fibrillation with dual-site right atrial pacing and antiarrhythmic drug therapy

Saksena, S., Prakash, A., Ziegler, P., Hummel, J. D., Friedman, P., Plumb, V. J., Wyse, D. G., Johnson, E., Fitts, S., & Mehra, R. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02068-5 · Cited by 171

Oral anticoagulation, aspirin, or no therapy in patients with nonvalvular AF with 0 or 1 stroke risk factor based on the CHA2DS2-VASc score

Lip, G. Y. H., Skjøth, F., Rasmussen, L. H., & Larsen, T. B. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.01.044 · Cited by 171

Predictors for atrial fibrillation detection after cryptogenic stroke: Results from CRYSTAL AF

Thijs, V. N., Brachmann, J., Morillo, C. A., Passman, R. S., Sanna, T., Bernstein, R. A., Diener, H.-C., Di Lazzaro, V., Rymer, M. M., Hogge, L., et al. (2016) · Neurology · doi:10.1212/wnl.0000000000002282 · Cited by 170

Silent cerebral events/lesions related to atrial fibrillation ablation: a clinical review

DENEKE, T., JAIS, P., SCAGLIONE, M., SCHMITT, R., DI BIASE, L., CHRISTOPOULOS, G., SCHADE, A., MÜGGE, A., BANSMANN, M., NENTWICH, K., et al. (2015) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.12608 · Cited by 170

Physical Activity, Obesity, Weight Change, and Risk of Atrial Fibrillation: The Atherosclerosis Risk in Communities Study

Huxley, R. R., Misialek, J. R., Agarwal, S. K., Loehr, L. R., Soliman, E. Z., Chen, L. Y., & Alonso, A. (2014) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.113.001244 · Cited by 169

Risks of Intracranial Hemorrhage Among Patients With Acute Ischemic Stroke Receiving Warfarin and Treated With Intravenous Tissue Plasminogen Activator

Xian, Y., Liang, L., Smith, E. E., Schwamm, L. H., Reeves, M. J., Olson, D. M., Hernandez, A. F., Fonarow, G. C., & Peterson, E. D. (2012) · JAMA · doi:10.1001/jama.2012.6756 · Cited by 169

Ethnic Differences in Patient Perceptions of Atrial Fibrillation and Anticoagulation Therapy: The West Birmingham Atrial Fibrillation Project

Lip, G. Y. H., Kamath, S., Jafri, M., Mohammed, A., & Bareford, D. (2002) · Stroke · doi:10.1161/hs0102.101817 · Cited by 168

Ventricular fibrillation and sudden death after radiofrequency catheter ablation of the atrioventricular junction

GEELEN, P., BRUGADA, J., ANDRIES, E., & BRUGADA, P. (1997) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.1997.tb06179.x · Cited by 168

Time to cardioversion for acute atrial fibrillation and thromboembolic complications

Nuotio, I., Hartikainen, J. E. K., Grönberg, T., Biancari, F., & Airaksinen, K. E. J. (2014) · JAMA · doi:10.1001/jama.2014.3824 · Cited by 167

Surgical left atrial appendage occlusion during cardiac surgery for patients with atrial fibrillation: a meta-analysis

Tsai, Y.-C., Phan, K., Munkholm-Larsen, S., Tian, D. H., La Meir, M., & Yan, T. D. (2015) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezu291 · Cited by 167

What is ‘valvular’ atrial fibrillation? A reappraisal

Caterina, R. D., & Camm, A. J. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu352 · Cited by 166

Accuracy of diagnosing atrial fibrillation on electrocardiogram by primary care practitioners and interpretative diagnostic software: analysis of data from screening for atrial fibrillation in the elderly (SAFE) trial

Mant, J., Fitzmaurice, D. A., Hobbs, R. F., Jowett, S. M., Murray, E. T., HOLDER, R. L., Davies, M., & Lip, G. Y. H. (2007) · BMJ · doi:10.1136/bmj.39227.551713.ae · Cited by 165

Catheter ablation of atrial fibrillation in patients with diabetes mellitus type 2: results from a randomized study comparing pulmonary vein isolation versus antiarrhythmic drug therapy

FORLEO, G. B., MANTICA, M., DE LUCA, L., LEO, R., SANTINI, L., PANIGADA, S., DE SANCTIS, V., PAPPALARDO, A., LAURENZI, F., AVELLA, A., et al. (2009) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2008.01275.x · Cited by 165

Does intensity of rate-control influence outcome in atrial fibrillation? An analysis of pooled data from the RACE and AFFIRM studies

Van Gelder, I. C., Wyse, D. G., Chandler, M. L., Cooper, H. A., Olshansky, B., Hagens, V. E., & Crijns, H. J. G. M. (2006) · EP Europace · doi:10.1093/europace/eul106 · Cited by 165

Non-vitamin K antagonist oral anticoagulation agents in anticoagulant naive atrial fibrillation patients: Danish nationwide descriptive data 2011-2013

Olesen, J. B., Sørensen, R., Hansen, M. L., Lamberts, M., Weeke, P. E., Mikkelsen, A. P., Køber, L., Gislason, G., Torp-Pedersen, C. T., & Fosbøl, E. L. (2014) · EP Europace · doi:10.1093/europace/euu225 · Cited by 165

Effects of Oral Propafenone Administration Before Electrical Cardioversion of Chronic Atrial Fibrillation: A Placebo-Controlled Study

Bianconi, L., Mennuni, M., Lukic, V., Castro, A., Chieffi, M., & Santini, M. (1996) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(96)00230-6 · Cited by 165

The Effect of Rate Control on Quality of Life in Patients With Permanent Atrial Fibrillation

Groenveld, H. F., Crijns, H. J. G. M., Van den Berg, M. P., Van Sonderen, E., Alings, A. M., Tijssen, J. G. P., Hillege, H. L., Tuininga, Y. S., Van Veldhuisen, D. J., Ranchor, A. V., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.06.055 · Cited by 164

Predictors of Systemic Embolism in Patients with Mitral Stenosis: A Prospective Study

Chiang, C., Lo, S. K., Ko, Y. S., Cheng, N., Lin, P. J., & Chang, C. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-11-199806010-00001 · Cited by 164

The HARMONY Trial

Reiffel, J. A., Camm, A. J., Belardinelli, L., Zeng, D., Karwatowska‐Prokopczuk, E., Olmsted, A., Zaręba, W., Rosero, S. Z., & Kowey, P. R. (2015) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.115.002856 · Cited by 164

Relationship Between Pulmonary Vein Reconnection and Atrial Fibrillation Recurrence

Nery, P. B., Belliveau, D. J., Nair, G. M., Bernick, J., Redpath, C. J., Szczotka, A., Sadek, M. M., Green, M. S., Wells, G. A., & Birnie, D. H. (2016) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2016.02.003 · Cited by 164

Asymptomatic versus symptomatic atrial fibrillation: A systematic review of age/gender differences and cardiovascular outcomes

Xiong, Q., Proietti, M., Senoo, K., & Lip, G. Y. H. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.05.011 · Cited by 161

Atrial fibrillation associated with ivabradine treatment: meta-analysis of randomised controlled trials

Martin, R. I. R., Pogoryelova, O., Koref, M. S., Bourke, J. P., Teare, M. D., & Keavney, B. D. (2014) · Heart · doi:10.1136/heartjnl-2014-305482 · Cited by 161

Balancing stroke and bleeding risks in patients with atrial fibrillation and renal failure: the Swedish Atrial Fibrillation Cohort study

Friberg, L., Benson, L., & Lip, G. Y. H. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehu139 · Cited by 161

Genetics of Arrhythmogenic Right Ventricular Cardiomyopathy

Marcus, F. I., Edson, S., & Towbin, J. A. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.01.073 · Cited by 159

Brugada syndrome and supraventricular tachyarrhythmias: a novel association?

ECKARDT, L., KIRCHHOF, P., LOH, P., SCHULZE‐BAHR, E., JOHNA, R., WICHTER, T., BREITHARDT, G., HAVERKAMP, W., & BORGGREFE, M. (2001) · Journal of Cardiovascular Electrophysiology · doi:10.1046/j.1540-8167.2001.00680.x · Cited by 159

Efficacy of an additional MAZE procedure using cooled-tip radiofrequency ablation in patients with chronic atrial fibrillation and mitral valve disease. A randomized, prospective trial

Deneke, T. (2002) · European Heart Journal · doi:10.1053/euhj.2001.2841 · Cited by 159

Effect of statins on atrial fibrillation: collaborative meta-analysis of published and unpublished evidence from randomised controlled trials

Rahimi, K., Emberson, J., McGale, P., Majoni, W., Merhi, A., Asselbergs, F. W., Krane, V., Macfarlane, P. W., & Executive, P. I. A. O. B. O. T. P. (2011) · BMJ · doi:10.1136/bmj.d1250 · Cited by 159

Meta-analysis: Inhibition of renin-angiotensin system prevents new-onset atrial fibrillation

Anand, K., Mooss, A. N., Hee, T. T., & Mohiuddin, S. M. (2006) · American Heart Journal · doi:10.1016/j.ahj.2006.01.007 · Cited by 159

Usefulness of postoperative atrial fibrillation as an independent predictor for worse early and late outcomes after isolated coronary artery bypass grafting (multicenter Australian study of 19,497 patients)

Saxena, A., Dinh, D. T., Smith, J. A., Shardey, G. C., Reid, C. M., & Newcomb, A. E. (2012) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.08.033 · Cited by 158

Effect of Sleep Apnea and Continuous Positive Airway Pressure on Cardiac Structure and Recurrence of Atrial Fibrillation

Neilan, T. G., Farhad, H., Dodson, J. A., Shah, R. V., Abbasi, S. A., Bakker, J. P., Michaud, G. F., van der Geest, R., Blankstein, R., Steigner, M., et al. (2013) · Journal of the American Heart Association · doi:10.1161/jaha.113.000421 · Cited by 158

Feasibility and safety of uninterrupted periprocedural apixaban administration in patients undergoing radiofrequency catheter ablation for atrial fibrillation: Results from a multicenter study

Di Biase, L., Lakkireddy, D., Trivedi, C., Deneke, T., Martinek, M., Mohanty, S., Mohanty, P., Prakash, S., Bai, R., Reddy, M., et al. (2015) · Heart Rhythm · doi:10.1016/j.hrthm.2015.02.028 · Cited by 158

Suppression of paroxysmal atrial tachyarrhythmias—results of the SOPAT trial

PATTEN, M., MAAS, R., BAUER, P., LUDERITZ, B., SONNTAG, F., DLUZNIEWSKI, M., HATALA, R., OPOLSKI, G., MULLER, H., & MEINERTZ, T. (2004) · European Heart Journal · doi:10.1016/j.ehj.2004.06.014 · Cited by 157

Diffuse Ventricular Fibrosis in Atrial Fibrillation

Ling, L.-H., Kistler, P. M., Ellims, A. H., Iles, L. M., Lee, G., Hughes, G. L., Kalman, J. M., Kaye, D. M., & Taylor, A. J. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.07.065 · Cited by 157

The Australian intervention randomized control of rate in atrial fibrillation trial (AIRCRAFT)

Weerasooriya, R., Davis, M., Powell, A., Szili‐Törok, T., Shah, C. P., Whalley, D. W., Kanagaratnam, L. B., HEDDLE, W. F., Leitch, J., Perks, A. M., et al. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00338-3 · Cited by 156

Catheter ablation in patients with persistent atrial fibrillation

Kirchhof, P. F., & Calkins, H. G. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw260 · Cited by 156

A randomized double-blind study of epicardial left atrial cryoablation for permanent atrial fibrillation in patients undergoing mitral valve surgery: the SWEDish Multicentre Atrial Fibrillation study (SWEDMAF)

Blomström‐Lundqvist, C., Johansson, B., Berglin, E., Nilsson, L., Jensen, S. M., Thelin, S., Holmgren, A., Edvardsson, N. G., Källner, G., & Blomström, P. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm378 · Cited by 155

Improving outcomes in patients with atrial fibrillation: rationale and design of the Early treatment of Atrial fibrillation for Stroke prevention Trial

Kirchhof, P., Breithardt, G., Camm, A. J., Crijns, H. J., Kuck, K.-H., Vardas, P., & Wegscheider, K. (2013) · American Heart Journal · doi:10.1016/j.ahj.2013.05.015 · Cited by 155

A randomized controlled trial to prevent post-operative atrial fibrillation by antioxidant reinforcement

Rodrigo, R., Korantzopoulos, P., Cereceda, M., Asenjo, R., Zamorano, J., Villalabeitia, E., Baeza, C., Aguayo, R., Castillo, R., Carrasco, R., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.07.014 · Cited by 154

Cost-effectiveness of mass screening for untreated atrial fibrillation using intermittent ECG recording

Aronsson, M., Svennberg, E., Rosenqvist, M., Engdahl, J., Al-Khalili, F., Friberg, L., Frykman-Kull, V., & Levin, L.-Å. (2015) · Europace · doi:10.1093/europace/euv083 · Cited by 154

Drivers of hospitalization for patients with atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)

Steinberg, B. A., Kim, S., Fonarow, G. C., Thomas, L., Ansell, J., Kowey, P. R., Mahaffey, K. W., Gersh, B. J., Hylek, E., Naccarelli, G., et al. (2014) · American Heart Journal · doi:10.1016/j.ahj.2014.02.003 · Cited by 154

Comparison of cardiac surgery with left atrial surgical ablation vs. cardiac surgery without atrial ablation in patients with coronary and/or valvular heart disease plus atrial fibrillation: final results of the PRAGUE-12 randomized multicentre study

Budera, P., Straka, Z., Osmancik, P., Vanek, T., Jelinek, S., Hlavicka, J., Fojt, R., Cervinka, P., Hulman, M., Smid, M., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs290 · Cited by 154

Outcomes in a Warfarin-Treated Population With Atrial Fibrillation

Björck, F., Renlund, H., Lip, G. Y. H., Wester, P., Svensson, P. J., & Själander, A. (2016) · JAMA Cardiology · doi:10.1001/jamacardio.2016.0199 · Cited by 153

Nonvitamin-K-Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and Previous Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Ntaios, G., Papavasileiou, V., Diener, H.-C., Makaritsis, K., & Michel, P. (2012) · Stroke · doi:10.1161/strokeaha.112.673558 · Cited by 152

Histopathological substrate for chronic atrial fibrillation in humans

Nguyen, B. L., Fishbein, M. C., Chen, L. S., Chen, P., & Masroor, S. (2009) · Heart Rhythm · doi:10.1016/j.hrthm.2009.01.010 · Cited by 151

Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: a report from the EORP-AF General Pilot Registry

Lip, G. Y. H., Laroche, C., Popescu, M. I., Rasmussen, L. H., Vitali-Serdoz, L., Dan, G.-A., Kalarus, Z., Crijns, H. J. G. M., Oliveira, M. M., Tavazzi, L., et al. (2015) · Europace · doi:10.1093/europace/euv269 · Cited by 151

Higher Persistence in Newly Diagnosed Nonvalvular Atrial Fibrillation Patients Treated With Dabigatran Versus Warfarin

Zalesak, M., Siu, K., Francis, K. M., Chen, Y. X., Alvrtsyan, H., Rao, Y., Walker, D. R., Sander, S. D., Miyasato, G., Matchar, D. B., et al. (2013) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.113.000192 · Cited by 151

Catheter ablation of atrial arrhythmias: state of the art

Lee, G., Sanders, P., & Kalman, J. M. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61463-9 · Cited by 151

Impact of clinical history and electrophysiologic characterization of accessory pathways on management strategies to reduce sudden death among children with Wolff-Parkinson-White syndrome

Bromberg, B. I., Lindsay, B. D., CAIN, M. E., & Cox, J. L. (1996) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00519-6 · Cited by 150

Risk of gastrointestinal bleeding associated with oral anticoagulants: population based retrospective cohort study

Chang, H., Zhou, M., Tang, W., Alexander, G. C., & Singh, S. (2015) · BMJ · doi:10.1136/bmj.h1585 · Cited by 150

Intravenous digoxin in acute atrial fibrillation: Results of a randomized, placebo-controlled multicentre trial in 239 patients

The Digitalis in Acute Atrial Fibrillation (DAAF) Trial Group (1997) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a015311 · Cited by 150

Diagnosis and treatment of catecholaminergic polymorphic ventricular tachycardia

Napolitano, C., & Priori, S. G. (2007) · Heart Rhythm · doi:10.1016/j.hrthm.2006.12.048 · Cited by 148

Dabigatran adherence in atrial fibrillation patients during the first year after diagnosis: a nationwide cohort study

Gorst‐Rasmussen, A., Skjøth, F., Larsen, T. B., Rasmussen, L. H., Lip, G. Y. H., & Lane, D. A. (2015) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12845 · Cited by 148

Novel genetic markers associate with atrial fibrillation risk in Europeans and Japanese

Lubitz, S. A., Lunetta, K. L., Lin, H., Arking, D. E., Trompet, S., Li, G., Krijthe, B. P., Chasman, D. I., Barnard, J., Kleber, M. E., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.12.015 · Cited by 148

Genotype-Guided Dosing of Coumarin Derivatives: The European Pharmacogenetics of Anticoagulant Therapy (EU-PACT) Trial Design

van Schie, R. M., Wadelius, M., Kamali, F., Daly, A. K., Manolopoulos, V. G., de Boer, A., Barallon, R. V., Verhoef, T. I., Kirchheiner, J., Haschke‐Becher, E., et al. (2009) · Pharmacogenomics · doi:10.2217/pgs.09.125 · Cited by 148

Atrial fibrillation ablation patients have long-term stroke rates similar to patients without atrial fibrillation regardless of CHADS2 score

Bunch, T. J., May, H. T., Bair, T. L., Weiss, J. P., Crandall, B. G., Osborn, J. S., Mallender, C. D., Anderson, J. L., Muhlestein, B., LAPPE, D. L., et al. (2013) · Heart Rhythm · doi:10.1016/j.hrthm.2013.07.002 · Cited by 147

Pretreatment with verapamil in patients with persistent or chronic atrial fibrillation who underwent electrical cardioversion

Simone, A. D., Stabile, G., Vitale, D. F., Turco, P., Stasio, M. D., Petrazzuoli, F., Gasparini, M., Matteis, C. D., Rotunno, R., & Napoli, T. D. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00256-9 · Cited by 147

Standard versus atrial fibrillation-specific management strategy (SAFETY) to reduce recurrent admission and prolong survival: pragmatic, multicentre, randomised controlled trial

Stewart, S., Ball, J., Horowitz, J. D., Marwick, T. H., Mahadevan, G., Wong, C., Abhayaratna, W. P., Chan, Y. K., Esterman, A., Thompson, D. R., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61992-9 · Cited by 147

Influence of Atrial Fibrillation on Outcome Following Mitral Valve Repair

Lim, E. K. S., Barlow, C. W., Hosseinpour, A., Wisbey, C., Wilson, K., Pidgeon, W., Charman, S. C., Barlow, J. B., & Wells, F. C. (2001) · Circulation · doi:10.1161/hc37t1.094813 · Cited by 146

Incidence and Prevention of Cardiac Tamponade Complicating Ablation for Atrial Fibrillation

Hsu, L., Jaı̈s, P., Hocini, M., Sanders, P., Scavée, C., Sacher, F., Takahashi, Y., Rotter, M., Pasquié, J., Clémenty, J., et al. (2005) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2005.00062.x · Cited by 146

Efficacy of Catheter Ablation for Persistent Atrial Fibrillation: A Systematic Review and Meta-Analysis of Evidence From Randomized and Nonrandomized Controlled Trials

Wynn, G. J., Das, M., Bonnett, L. J., Panikker, S., Wong, T., & Gupta, D. (2014) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.114.001759 · Cited by 146

Stroke and recurrent haemorrhage associated with antithrombotic treatment after gastrointestinal bleeding in patients with atrial fibrillation: nationwide cohort study

Staerk, L., Lip, G. Y. H., Olesen, J. B., Fosbøl, E. L., Pallisgaard, J. L., Bonde, A. N., Gundlund, A., Lindhardt, T. B., Hansen, M. L., Torp-Pedersen, C., et al. (2015) · BMJ · doi:10.1136/bmj.h5876 · Cited by 146

Single oral loading dose of propafenone for pharmacological cardioversion of recent-onset atrial fibrillation

Khan, I. A. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)01116-5 · Cited by 145

Safety and efficacy of well managed warfarin

Sjögren, V., Grzymala-Lubanski, B., Renlund, H., Friberg, L., Lip, G. Y. H., Svensson, P. J., & Själander, A. (2015) · Thrombosis and Haemostasis · doi:10.1160/th14-10-0859 · Cited by 145

Defining the major health modifiers causing atrial fibrillation: a roadmap to underpin personalized prevention and treatment

Fabritz, L., Guasch, E., Antoniades, C. A., Bardinet, I., Benninger, G., Betts, T. R., Brand, E., BREITHARDT, G. E., Suchánková, G., Camm, A. J., et al. (2015) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2015.194 · Cited by 144

Digoxin: The good and the bad

Ziff, O. J., & Kotecha, D. (2016) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2016.03.011 · Cited by 144

The association between kidney function and major bleeding in older adults with atrial fibrillation starting warfarin treatment: population based observational study

Jun, M., James, M. T., Manns, B. J., Quinn, R. R., Ravani, P., Tonelli, M., Perkovic, V., Winkelmayer, W. C., Ma, Z., Hemmelgarn, B. R., et al. (2015) · BMJ · doi:10.1136/bmj.h246 · Cited by 143

Effect of age and sex on efficacy and tolerability of β blockers in patients with heart failure with reduced ejection fraction: individual patient data meta-analysis

Kotecha, D., Manzano, L., Krum, H., Rosano, G. M. C., Holmes, J., Altman, D. G., Collins, P. D., Packer, M., Wikstrand, J., Coats, A. J. S., et al. (2016) · BMJ · doi:10.1136/bmj.i1855 · Cited by 143

New-onset atrial fibrillation following coronary bypass surgery predicts long-term mortality: a systematic review and meta-analysis

Phan, K., Ha, H. S. K., Phan, S., Medi, C., Thomas, S. P., & Yan, T. D. (2015) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezu551 · Cited by 143

Impact of Atrial Fibrillation on Tricuspid and Mitral Annular Dilatation and Valvular Regurgitation.

Zhou, X., Otsuji, Y., Yoshifuku, S., et al. (2002) · Circulation Journal · doi:10.1253/circj.66.913 · Cited by 143

A roadmap to improve the quality of atrial fibrillation management: proceedings from the fifth Atrial Fibrillation Network/European Heart Rhythm Association consensus conference

Kirchhof, P. F., BREITHARDT, G. E., Bax, J. J., Benninger, G., Blomström‐Lundqvist, C., Boriani, G., Brandes, A., Brown, H., Brueckmann, M., Calkins, H. G., et al. (2015) · EP Europace · doi:10.1093/europace/euv304 · Cited by 143

Recurrence of arrhythmia following short-term oral AMIOdarone after CATheter ablation for atrial fibrillation: a double-blind, randomized, placebo-controlled study (AMIO-CAT trial)

Darkner, S., Chen, X., Hansen, J., Pehrson, S., Johannessen, A., Nielsen, J. B., & Svendsen, J. H. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu354 · Cited by 142

Cardiac tachyarrhythmias and patient values and preferences for their management: the European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLEACE)

Lane, D. A., Aguinaga, L., Blomström-Lundqvist, C., Boriani, G., Dan, G.-A., Hills, M. T., Hylek, E. M., LaHaye, S. A., Lip, G. Y. H., Lobban, T., et al. (2015) · Europace · doi:10.1093/europace/euv233 · Cited by 142

Symptomatic Response to Antiarrhythmic Drug Therapy Is Modulated by a Common Single Nucleotide Polymorphism in Atrial Fibrillation

Parvez, B., Vaglio, J. C., Rowan, S. B., Muhammad, R., Kucera, G., Stubblefield, T., Carter, S., Roden, D. M., & Darbar, D. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.01.070 · Cited by 141

Personalized management of atrial fibrillation: Proceedings from the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association consensus conference

Kirchhof, P., Breithardt, G., Aliot, E., Al Khatib, S., Apostolakis, S., Auricchio, A., Bailleul, C., Bax, J., Benninger, G., Blomstrom-Lundqvist, C., et al. (2013) · Europace · doi:10.1093/europace/eut232 · Cited by 141

Management of Atrial Fibrillation in Patients With Structural Heart Disease

Darby, A. E., & Dimarco, J. (2012) · Circulation · doi:10.1161/circulationaha.111.019935 · Cited by 141

Omega-3 Fatty Acids for the Prevention of Recurrent Symptomatic Atrial Fibrillation

Macchia, A., Grancelli, H., Varini, S. D., Nul, D. R., Laffaye, N., Mariani, J. A., Ferrante, D., Badra, R., Figal, J. C., Ramos, S., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.11.021 · Cited by 140

Patient selection in heart failure with preserved ejection fraction clinical trials

Kelly, J. P., Mentz, R. J., Mebazaa, A., Voors, A. A., Butler, J., Roessig, L., Fiuzat, M., Zannad, F., Pitt, B., O’Connor, C. M., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.03.043 · Cited by 139

Review of epidemiology and management of atrial fibrillation in developing countries

Nguyen, T. N., Hilmer, S. N., & Cumming, R. G. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.01.184 · Cited by 139

Prospective randomized comparison between a fixed ‘2C3L’ approach vs. stepwise approach for catheter ablation of persistent atrial fibrillation

Dong, J., Sang, C., Yu, R., et al. (2015) · EP Europace · doi:10.1093/europace/euv067 · Cited by 139

Validation and clinical use of a novel diagnostic device for screening of atrial fibrillation

Tieleman, R. G., Plantinga, Y., Rinkes, D., Bartels, G. L., Posma, J. L., Cator, R., Hofman, C., & Houben, R. P. (2014) · Europace · doi:10.1093/europace/euu057 · Cited by 138

Efficacy of catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy: impact of age, atrial remodelling, and disease progression

Di Donna, P., Olivotto, I., Delcre, S. D. L., Caponi, D., Scaglione, M., Nault, I., Montefusco, A., Girolami, F., Cecchi, F., Haissaguerre, M., et al. (2010) · Europace · doi:10.1093/europace/euq013 · Cited by 138

Cell size and communication: Role in structural and electrical development and remodeling of the heart

Spach, M. S., Heidlage, J. F., Barr, R. C., & Dolber, P. C. (2004) · Heart Rhythm · doi:10.1016/j.hrthm.2004.06.010 · Cited by 137

Determinants of atrial fibrillation development in patients with hypertrophic cardiomyopathy

Losi, M. A., Betocchi, S., Aversa, M., Lombardi, R., Miranda, M., D’Alessandro, G., Cacace, A., Tocchetti, C. G., Barbati, G., & Massimo Chiariello, A. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.06.024 · Cited by 137

Heart failure epidemiology: European perspective

Guha, K., & McDonagh, T. (2013) · Current Cardiology Reviews · doi:10.2174/1573403x11309020005 · Cited by 137

Female sex as a risk factor for stroke in atrial fibrillation: a nationwide cohort study

MIKKELSEN, A. P., LINDHARDSEN, J., LIP, G. Y. H., GISLASON, G. H., TORP‐PEDERSEN, C., & OLESEN, J. B. (2012) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2012.04853.x · Cited by 137

Symptoms, functional status and quality of life in patients with controlled and uncontrolled atrial fibrillation: data from the RealiseAF cross-sectional international registry

Steg, P. G., Alam, S., Chiang, C., Gamra, H., Goethals, M., Inoue, H., Krapf, L., Lewalter, T., Merioua, I., Murín, J., et al. (2011) · Heart · doi:10.1136/heartjnl-2011-300550 · Cited by 137

Thromboembolic risk in 16 274 atrial fibrillation patients undergoing direct current cardioversion with and without oral anticoagulant therapy

Hansen, M. L., Jepsen, R. M. H. G., Olesen, J. B., Ruwald, M. H., Karasoy, D., Gislason, G., Hansen, J., Køber, L., Husted, S., & Torp-Pedersen, C. T. (2014) · EP Europace · doi:10.1093/europace/euu189 · Cited by 136

Recommendations for participation in leisure-time physical activity and competitive sports in patients with arrhythmias and potentially arrhythmogenic conditions Part I: Supraventricular arrhythmias and pacemakers

Hein, H., Panhuyzen-Goedkoop, N., Corrado, D., Hoffmann, E., Biffi, A., Delise, P., Blomstrom-Lundqvist, C., Vanhees, L., IvarHoff, P., Dorwarth, U., et al. (2006) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/01.hjr.0000216543.54066.72 · Cited by 134

Prognostic value of non-sustained ventricular tachycardia and the potential role of amiodarone treatment in hypertrophic cardiomyopathy: assessment in an unselected non-referral based patient population

Cecchi, F., Olivotto, I., Montereggi, A., Squillatini, G., Dolara, A., & Maron, B. J. (1998) · Heart · doi:10.1136/hrt.79.4.331 · Cited by 134

2018 ESC/EACTS guidelines on myocardial revascularization

Neumann, F.-J., Sousa-Uva, M., Ahlsson, A., Alfonso, F., Banning, A. P., Benedetto, U., Byrne, R. A., Collet, J.-P., Falk, V., Head, S. J., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehy394 · Cited by 7,167

2020 ESC guidelines on sports cardiology and exercise in patients with cardiovascular disease

Pelliccia, A., Sharma, S., Gati, S., Bäck, M., Börjesson, M., Caselli, S., Collet, J.-P., Corrado, D., Drezner, J. A., Halle, M., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehaa605 · Cited by 1,958

American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism

Ortel, T. L., Neumann, I., Ageno, W., Beyth, R., Clark, N. P., Cuker, A., Hutten, B. A., Jaff, M. R., Manja, V., Schulman, S., et al. (2020) · Blood Advances · doi:10.1182/bloodadvances.2020001830 · Cited by 1,489

An Internet-Based Cognitive Behavioral Therapy Program Adapted to Patients With Cardiovascular Disease and Depression: Randomized Controlled Trial

Johansson, P., Westas, M., Andersson, G., Alehagen, U., Broström, A., Jaarsma, T., Mourad, G., & Lundgren, J. (2019) · JMIR Mental Health · doi:10.2196/14648 · Cited by 77

A systematic review of network meta-analyses among patients with nonvalvular atrial fibrillation: a comparison of efficacy and safety following treatment with direct oral anticoagulants

Cohen, A. T., Hill, N. R., Luo, X., Masseria, C., Abariga, S. A., & Ashaye, A. O. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.06.114 · Cited by 57

Emergency management of atrial fibrillation

Wakai, A., & O’Neill, J. (2003) · Postgraduate Medical Journal · doi:10.1136/pmj.79.932.313 · Cited by 34

Evolving perspectives for personalised management of patients with atrial fibrillation

Kirchhof, P. F. (2014) · Heart · doi:10.1136/heartjnl-2013-305146 · Cited by 2

[Therapeutic approach to the epidemic of atrial fibrillation].

Fuster, V. (2002) · PubMed · Cited by 1

Atrial fibrillation: management strategies in the emergency department.

Oishi, M. L., & Xing, S. X. (2013) · PubMed · Cited by 9

Overview of management of atrial fibrillation in symptomatic elderly patients: pharmacologic therapy versus AV node ablation

Bradley, D. J., & Shen, W.-K. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100062 · Cited by 20